Studies have demonstrated that an elevated NAS/melatonin ratio promotes breast cancer cell survival and metastasis by mimicking brain-derived neurotrophic factor (BDNF) through TrkB receptor activation (Jang et al., 2010; Anderson, 2019a; Anderson, 2019b). This evidence concerns the gene BDNF and breast carcinoma.